Physician profile
Sarah Johnson
NPI 1245496538
$2,420.90
in general payments reported to CMS, 2019-2025
14 companies · $623 in 2025
The $623 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $193 · 2021: $505 · 2022: $618 · 2023: $28.19 · 2024: $230 · 2025: $623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638 · Travel and Lodging: $225 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $638.21 |
| Travel and Lodging | $224.87 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $446.95 | 2019-2025 | Tryptyr |
| Biotissue Holdings INC. | $440.97 | 2020-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $292.85 | 2020-2021 | |
| Abbvie INC. | $220.43 | 2022-2024 | |
| Dompe US, INC. | $199.29 | 2025 | Oxervate |
| Bausch & Lomb Americas INC. | $185.38 | 2022-2024 | Miebo |
| Allergan, INC. | $148.55 | 2021-2022 | |
| Johnson & Johnson Vision Care, INC. | $128.58 | 2021-2022 | |
| Horizon Therapeutics Plc | $123.73 | 2021 | |
| Sun Pharmaceutical Industries INC. | $96.93 | 2022-2025 | |
| Optovue, INC. | $65.22 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $32.50 | 2020 | |
| Philips North America LLC | $21.59 | 2019 | |
| Sight Sciences, INC. | $17.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.